Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A 2025 Nature Medicine study of 200,000+ patients found: 2.02.5x higher risk of drug-induced pancreatitis Higher incidence of kidney stones and arthritis Chronic pancreatitis can permanently damage the pancreas and raises long-term cancer risk
At the same time, multiple blockbuster GLP-1 therapies are already on the market (Ozempic, Wegovy, and Mounjaro), with numerous next-generation analogues and combination incretin therapies currently in development
Discovered in the 1970s, GHK-Cu has been studied for its ability to stimulate wound healing , improve skin elasticity , and promote hair growth
Future Outlook Retatrutide is the face of a new class of obesity drugs
US$ 28.53
US$ 24.94
US$ 27.22
